BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33049369)

  • 1. Impact microindentation in men with impaired fasting glucose and type 2 diabetes.
    Holloway-Kew KL; Betson A; Rufus-Membere PG; Gaston J; Diez-Perez A; Kotowicz MA; Pasco JA
    Bone; 2021 Jan; 142():115685. PubMed ID: 33049369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone material strength index is associated with prior fracture in men with and without moderate chronic kidney disease.
    Holloway-Kew KL; Rufus-Membere P; Anderson KB; Betson A; Gaston J; Kotowicz MA; Diez-Perez A; Hyde NK; Pasco JA
    Bone; 2020 Apr; 133():115241. PubMed ID: 31954850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density in diabetes and impaired fasting glucose.
    Holloway-Kew KL; Marijanovic N; De Abreu LLF; Sajjad MA; Pasco JA; Kotowicz MA
    Osteoporos Int; 2019 Sep; 30(9):1799-1806. PubMed ID: 31367948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trabecular Bone Score in Men and Women with Impaired Fasting Glucose and Diabetes.
    Holloway KL; De Abreu LLF; Hans D; Kotowicz MA; Sajjad MA; Hyde NK; Pasco JA
    Calcif Tissue Int; 2018 Jan; 102(1):32-40. PubMed ID: 28965154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.
    Pérez-Sáez MJ; Herrera S; Prieto-Alhambra D; Vilaplana L; Nogués X; Vera M; Redondo-Pachón D; Mir M; Güerri R; Crespo M; Díez-Pérez A; Pascual J
    Osteoporos Int; 2017 Sep; 28(9):2723-2727. PubMed ID: 28497224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Bone Impact Microindentation and Clinical Risk Factors for Fracture.
    Rufus-Membere P; Holloway-Kew KL; Diez-Perez A; Kotowicz MA; Pasco JA
    Endocrinology; 2019 Sep; 160(9):2143-2150. PubMed ID: 31310275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral quantitative computed tomography-derived bone parameters in men with impaired fasting glucose and diabetes.
    Holloway-Kew KL; Anderson KB; Tembo MC; Sui SX; Harland JW; Hyde NK; Kotowicz MA; Pasco JA
    J Bone Miner Metab; 2023 Jan; 41(1):131-142. PubMed ID: 36550385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Bone Material Strength Index Is Positively Associated With the Risk of Incident Osteoporotic Fractures in Older Swedish Women.
    Jaiswal R; Zoulakis M; Axelsson KF; Darelid A; Rudäng R; Sundh D; Litsne H; Johansson L; Lorentzon M
    J Bone Miner Res; 2023 Jun; 38(6):860-868. PubMed ID: 37088885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Turnover Markers in Men and Women with Impaired Fasting Glucose and Diabetes.
    Holloway-Kew KL; De Abreu LLF; Kotowicz MA; Sajjad MA; Pasco JA
    Calcif Tissue Int; 2019 Jun; 104(6):599-604. PubMed ID: 30680432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is trabecular bone score less affected by degenerative-changes at the spine than lumbar spine BMD?
    Anderson KB; Holloway-Kew KL; Mohebbi M; Kotowicz MA; Hans D; Pasco JA
    Arch Osteoporos; 2018 Nov; 13(1):127. PubMed ID: 30446835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRAX (Australia) scores in women with impaired fasting glucose and diabetes.
    de Abreu LLF; Holloway-Kew KL; Sajjad MA; Kotowicz MA; Pasco JA
    Bone Rep; 2019 Dec; 11():100223. PubMed ID: 31463338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.
    Schoeb M; Winter EM; Malgo F; Schipper IB; van der Wal RJP; Papapoulos SE; Appelman-Dijkstra NM
    Osteoporos Int; 2022 Jul; 33(7):1511-1519. PubMed ID: 35307747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between femoral neck and LS-BMD with LS-TBS in T2DM patients: a case control study.
    Delbari N; Rajaei A; Oroei M; Ahmadzadeh A; Farsad F
    BMC Musculoskelet Disord; 2021 Jun; 22(1):582. PubMed ID: 34172019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone material strength in normoglycemic and hyperglycemic black and white older adults.
    Dawson-Hughes B; Bouxsein M; Shea K
    Osteoporos Int; 2019 Dec; 30(12):2429-2435. PubMed ID: 31463589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between bone density and bone material strength index in three siblings with Camurati-Engelmann disease.
    Herrera S; Soriano R; Nogués X; Güerri-Fernandez R; Grinberg D; García-Giralt N; Martínez-Gil N; Castejón S; González-Lizarán A; Balcells S; Diez-Perez A
    Osteoporos Int; 2017 Dec; 28(12):3489-3493. PubMed ID: 28842728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Material Strength Index as Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism.
    Schoeb M; Winter EM; Sleddering MA; Lips MA; Schepers A; Snel M; Appelman-Dijkstra NM
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2527-e2534. PubMed ID: 33780545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Type-2 Diabetes Subjects Trabecular Bone Score is Better Associated with Carotid Intima-Media Thickness than BMD.
    Caffarelli C; Giambelluca A; Ghini V; Francolini V; Pitinca MDT; Nuti R; Gonnelli S
    Calcif Tissue Int; 2017 Oct; 101(4):404-411. PubMed ID: 28664329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature.
    Schoeb M; Hamdy NAT; Malgo F; Winter EM; Appelman-Dijkstra NM
    Front Endocrinol (Lausanne); 2020; 11():15. PubMed ID: 32117052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Density, Microarchitecture, and Tissue Quality Long-term After Kidney Transplant.
    Pérez-Sáez MJ; Herrera S; Prieto-Alhambra D; Nogués X; Vera M; Redondo-Pachón D; Mir M; Güerri R; Crespo M; Díez-Pérez A; Pascual J
    Transplantation; 2017 Jun; 101(6):1290-1294. PubMed ID: 27467533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between bone measures and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers.
    Holloway-Kew KL; Betson AG; Anderson KB; Gaston J; Kotowicz MA; Liao WH; Henneberg M; Pasco JA
    Arch Osteoporos; 2021 Sep; 16(1):137. PubMed ID: 34536130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.